Cited by 149Mental Health Treatment and AccessTreatment of Major DepressionCardiac Health and Mental Health

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Impact of Major Depressive Disorder on Comorbidities: A Systematic Literature Review

Open access

Arnaud, Alix M., Brister, Teri S., Duckworth, Ken, Foxworth, Phyllis, Fulwider, Tonya, Suthoff, Ellison D., Werneburg, Brian, Aleksanderek, Izabela, Reinhart, Marcia L.·2022·The Journal of Clinical Psychiatry

DOI 10.4088/jcp.21r14328

Open this paper in CoChat — free account Open PDF

Abstract

To summarize the breadth of data exploring the relationship between major depressive disorder (MDD) and both the incidence and the disease course of a range of comorbidities. The authors searched MEDLINE, Embase, PsycINFO, Cochrane Database of Systematic Reviews, and several prespecified congresses. Searches included terms related to MDD and several comorbidity categories, restricted to those published in the English language from 2005 onward. Eligibility criteria included observational studies within North America and Europe that examined the covariate-adjusted impact of MDD on the risk and/or severity of comorbidities. A total of 6,811 articles were initially identified for screening. : Two investigators extracted data and assessed study quality. < .05) associated with an increased incidence of dementia and Alzheimer's disease as well as cognitive decline in individuals with existing disease; increased incidence and worsening of cardiovascular disease/events (although mixed results were found for stroke); worsening of metabolic syndrome; increased incidence of diabetes, particularly among men, and worsening of existing diabetes; increased incidence of obesity, particularly among women; increased incidence and worsening of certain autoimmune diseases; increased incidence and severity of HIV/AIDS; and increased incidence of drug abuse and severity of both alcohol and drug abuse. The presence of MDD was identified as a risk factor for both the development and the worsening of a range of comorbidities. These results highlight the importance of addressing depression early in its course and the need for integrating mental and general health care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.4088/jcp.21r14328

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476

Show all 1 references

Sorted by citations

Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“44 The impact of depression on society and the economy is increased by the existence of comorbidities.”
Background
Glutamatergic Modulators for Major Depression from Theory to Clinical Use
McIntyre, R. S., & Jain, R. (2024) · CNS Drugs · doi:10.1007/s40263-024-01114-y · Cited by 69
Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives
Pelzer, N., de Boer, I., van den Maagdenberg, A. M. J. M., & Terwindt, G. M. (2023) · Cephalalgia · doi:10.1177/03331024231180564 · Cited by 70
The microbiota–gut–brain axis in mental and neurodegenerative disorders: opportunities for prevention and intervention
Yassin, L. K., Skrabulyte-Barbulescu, J., Alshamsi, S. H., Saeed, S., Alkuwaiti, S. H., Almazrouei, S., Alnuaimi, A., BaniYas, S., Aldhaheri, D., Alderei, M., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1667448 · Cited by 48
Effectiveness of vortioxetine in patients with major depressive disorder and early-stage dementia: The MEMORY study
Christensen, M. C., Schmidt, S. N., & Grande, I. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.06.024 · Cited by 38
Decoding the inflammatory signature of the major depressive episode: insights from peripheral immunophenotyping in active and remitted condition, a case–control study
Daray, F. M., Grendas, L. N., Arena, Á. R., Tifner, V., Casiani, R. I. Á., Olaviaga, A., Chiapella, L. C., Vázquez, G. H., Penna, M. B., Hunter, F., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02902-2 · Cited by 32
The effect of inflammation markers on cortical thinning in major depressive disorder: A possible mediator of depression and cortical changes
Kang, Y., Shin, D., Kim, A., You, S., Kim, B., Han, K., & Ham, B. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.12.071 · Cited by 30
Major depressive disorder and the gut microbiome: what is the link?
Modesto‐Lowe, V., Chaplin, M., & Sgambato, D. (2023) · General Psychiatry · doi:10.1136/gpsych-2022-100973 · Cited by 25
Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health
Kalaria, R. N., Akinyemi, R., Paddick, S., & Ihara, M. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2273393 · Cited by 28
Phenome-wide investigation of bidirectional causal relationships between major depressive disorder and common human diseases
Sun, W.-X., Baranova, A. V., Liu, D., Cao, H., Zhang, X., & Zhang, F. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03216-z · Cited by 22
Mapping Disease Burden of Major Depressive Disorder and Its Risk Factors in Low- and Middle-Income Countries
Yu, Q., Xue, F., Wik, S. L., Gao, M., Adebisi, Y. A., Lucero‐Prisno, D. E., Zhong, C. C., Wong, M. C. S., Huang, J., & Global Health Focus Epidemiology Group (2025) · Psychotherapy and Psychosomatics · doi:10.1159/000547927 · Cited by 16
The magnitude and sustainability of treatment benefit of zuranolone on function and well-being as assessed by the SF-36 in adult patients with MDD and PPD: An integrated analysis of 4 randomized clinical trials
Clayton, A. H., Suthoff, E. D., Jain, R., Kosinski, M. R., Fridman, M., Deligiannidis, K. M., Meltzer-Brody, S. E., Chen, S., Gervitz, L. M., Huang, M., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.268 · Cited by 17
Self-citation
Impact of Treating Depression on Associated Comorbidities
Arnaud, A. M., Brister, T. S., Duckworth, K., Foxworth, P. M., Fulwider, T., Suthoff, E. D., WERNEBURG, B. G., Aleksanderek, I., & Reinhart, M. L. (2022) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.22r03330 · Cited by 19
Self-citation
From Monoamines to Systems Psychiatry: Rewiring Depression Science and Care (1960s–2025)
Tanaka, M. (2025) · Biomedicines · doi:10.3390/biomedicines14010035 · Cited by 18
Techniques for Measurement of Serotonin: Implications in Neuropsychiatric Disorders and Advances in Absolute Value Recording Methods
Cabrera, J. M. R., Oesterle, T., Rusheen, A. E., Goyal, A., Scheitler, K. M., Mandybur, I., Blaha, C. D., Bennet, K. E., Heien, M. L., Jang, D. P., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00618 · Cited by 14
Comparing analog and digital neurocognitive tests with older adults: a study of the ISPOCD battery vs. a digital test battery from Mindmore
Amirpour, A., Eckerblad, J., Bergman, L., & Nilsson, U. G. (2024) · BMC Geriatrics · doi:10.1186/s12877-023-04648-w · Cited by 12
A Delphi consensus on clinical features, diagnosis and treatment of major depressive disorder patients with anhedonia amongst psychiatrists in the Asia-Pacific
Cheng, C. P. W., Herr, K. J., Jeon, H. J., Kato, T., Ng, C. H., Yang, Y. K., & Zhang, L. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1338063 · Cited by 12
The effectiveness of Transcranial Photobiomodulation therapy (tPBM) on reducing anxiety, depression, and opioid craving in patients undergoing methadone maintenance treatment: a double-blind, randomized, controlled trial
Helali, H., Samani, N., Tabeie, F., Eiliaei, S., & Kheradmand, A. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06555-3 · Cited by 12
Terahertz photoneuromodulation of lateral orbitofrontal cortex neurons ameliorates stress-induced depression and cognitive impairment
Yuanyuan, H., Ma, J., Yu, Y., Yin, J., Gao, G., Yuan, Y., Ruan, H., Yan, X., Song, Z., & Chang, C. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.12.004 · Cited by 11
Depressive symptoms and their severity in a sample with lymphedema: a case–control investigation
Monteiro, A. J., de Labra, C., Losa‐Iglesias, M. E., Días, A., Vallejo, R., Silva-Migueis, H., Cardoso, P., López‐López, D., & Gómez-Salgado, J. C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1202940 · Cited by 11
Examining the needs, outcomes and current treatment pathways of 2461 people with treatment-resistant depression: mixed-methods study
Gill, K., Hett, D., Carlish, M., Amos, R., Khatibi, A., Morales‐Muñoz, I., & Marwaha, S. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2024.275 · Cited by 13
Systemic Inflammation at the Crossroad of Major Depressive Disorder and Comorbidities: A Narrative Review
Vitali, E., Cattane, N., D’Aprile, I., Petrillo, G., & Cattaneo, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199382 · Cited by 10
Dual-specificity protein phosphatase 6 (DUSP6) overexpression reduces amyloid load and improves memory deficits in male 5xFAD mice
Pan, A. L., Audrain, M., Sakakibara, E., Joshi, R., Zhu, X., Wang, Q., Wang, M., Beckmann, N. D., Schadt, E. E., Gandy, S., et al. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1400447 · Cited by 9
Developing a translational research framework for MDD: combining biomolecular mechanisms with a spiraling risk factor model
van Baalen, M., van der Velden, L., van der Gronde, T., & Pieters, T. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1463929 · Cited by 10
Occult, undiagnosed obstructive sleep apnea increases risk of depression among a national sample of older adult Medicare beneficiaries
Wickwire, E. M., & Albrecht, J. S. (2023) · Sleep Health · doi:10.1016/j.sleh.2023.05.008 · Cited by 9
Cardiorespiratory fitness, perceived fitness and autonomic function in in-patients with different depression severity compared with healthy controls
Kreppke, J.-N., Cody, R., Beck, J., Brand, S., Donath, L., Eckert, A., Imboden, C., Hatzinger, M., Holsboer‐Trachsler, E., Lang, U. E., et al. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.05.044 · Cited by 9
Sexual Orientation Disparities in Depression and Substance Use Among Adults: Results from the Brazilian National Health Survey 2019
Gomes, N. L., & Lopes, C. D. S. (2023) · LGBT Health · doi:10.1089/lgbt.2022.0193 · Cited by 8
Sex differences evident in elevated anxiety symptoms in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis
Joyees, J., Marrie, R. A., Bernstein, C. N., Bolton, J. M., Fisk, J. D., Graff, L. A., Hitchon, C. A., Patten, S. B., Kowalec, K., & for the CIHR team in defining the burden and managing the effects of psychiatric comorbidity in chronic immunoinflammatory disease (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1260420 · Cited by 8
Schizophrenia, bipolar disorder and major depressive disorder are probably not risk factors for cardiovascular disease: A Mendelian randomized study
Chen, J., Duan, W., Liu, P., Cui, L., Li, A., Zhang, X., & Zuo, X. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.02.069 · Cited by 9
A Comprehensive Review on Major Depressive Disorder: Exploring Etiology, Pathogenesis and Clinical Approaches
Mehra, A., Khanna, J., Singh, G., Sachdeva, V., & Bedi, N. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-025-00308-y · Cited by 8
Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial
Durgam, S., Earley, W. R., Kozauer, S. G., Mo, Y., Lakkis, H. D., Edwards, J. B., Kornstein, S. G., & D, M. F. M. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20250292 · Cited by 9
Leveraging DNA methylation to predict treatment response in major depressive disorder: A critical review
Dahrendorff, J., Currier, G. W., & Uddin, M. (2024) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32985 · Cited by 9
Omega-3 polyunsaturated fatty acids in depression: insights from recent clinical trials
Dyall, S. C., Malau, I. A., & Su, K. (2024) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000001077 · Cited by 11
Impact of living with an adult with depressive symptoms among households in the United States
Greenberg, P. E., O’Callaghan, L., Fournier, A.-A., Gagnon‐Sanschagrin, P., Maitland, J., & Chitnis, A. S. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.12.040 · Cited by 8
Acceptance and Commitment Therapy for Major Depressive Disorder: Navigating Depression Treatment in Traditional and Digital Settings with Insights from Current Research
Apolinário-Hagen, J., Drüge, M., Guthardt, L., & Haller, E. (2024) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-97-4402-2_12 · Cited by 6
Clinical and etiopathogenetic aspects of depressive and anxiety disorders’ comorbidity: towards the problem of achieving stable remission
Караваева, Т. А., Vasileva, A. V., Radionov, D. S., Андреевна, С. Д., & Andrianova, A. E. (2024) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2024-975 · Cited by 9
Spravato for Treatment-Resistant Depression: Efficacy and Sexual Side Effect Profile
Raza, A., Ahmed, G. U., Zafar, H., Akhtar, S. O., Mobin, M. B., & Samadi, A. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s548944 · Cited by 6
External Validation of a Machine Learning Model for Schizophrenia Classification
He, Y., Sakuma, K., Kishi, T., Li, Y., Matsunaga, M., Tanihara, S., Iwata, N., & Ota, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102970 · Cited by 7
Daily Vinegar Ingestion Improves Depression and Enhances Niacin Metabolism in Overweight Adults: A Randomized Controlled Trial
Barrong, H., Coven, H., Lish, A., Fessler, S. N., Jasbi, P., & Johnston, C. S. (2024) · Nutrients · doi:10.3390/nu16142305 · Cited by 7
Interaction of artificial intelligence, mental disorders, and diverse data modalities: Potential treatment management based on the “method–disease–data” axis
Xu, T., Wang, N., Jin, Y., Chen, Y., & Ma, K. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00121 · Cited by 5
Exploring drug interactions between newer antidepressants and medications used to treat neurological disorders
Alborghetti, M., Barbieri, M. A., Nicoletti, F., & Spina, E. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2566692 · Cited by 5
Effectiveness of Vortioxetine Treatment on Depression and Cognitive Functions in Patients with Alzheimer’s Disease: A 12-Month, Retrospective, Observational Study
García‐Alberca, J. M., de la Guía, P., Gris, E., Mendoza, S., de la Rica, M. L., Barbancho, M. Á., Lara, J. P., & Blanco‐Reina, E. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14090918 · Cited by 5
Age-related variations in heart rate variability profiles among patients with schizophrenia and major depressive disorder
Gao, Y., Zhou, L., Wu, H., Wei, Y., Tang, X., Xu, L., Hu, Y., Hu, Q., Liu, H., Wang, Z., et al. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01942-5 · Cited by 5
Leptin a potential link between obesity and depression
Hontecillas‐Prieto, L., García-Domínguez, D. J., Berlanga-Gil, C., Flores-Campos, R., Muñoz-Pacheco, R., Franco-Fernández, M. D., Flores-Cordero, J. A., Sánchez-Jiménez, F., Pérez‐Pérez, A., Vilariño‐García, T., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05892-6 · Cited by 7
Prevalence and Comorbidities Among Individuals With Rheumatoid Arthritis in the Saudi Arabian Context
Alghamdi, M. A. A., Somaily, M. Y., Alemam, S. Y., Majadah, S., Hassan, A. A. H., Meshary, A. A., Alasmri, S. A. A., Ali, M. S., Alsubaie, A. A., & Miskeen, E. (2024) · Cureus · doi:10.7759/cureus.53992 · Cited by 5
Mental Health Treatment among U.S. Military Veterans: Insights from the National Health Interview Survey
Marini, M., Gutkind, S., Livne, O., Fink, D. S., Saxon, A. J., Simpson, T. L., Sherman, S. E., & Mannes, Z. L. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-024-09320-6 · Cited by 4
Diabetes Complications Among Community-Based Health Center Patients with Varying Multimorbidity Patterns
Quiñones, A. R., Hwang, J. H., Huguet, N., Madlock‐Brown, C., Marino, M., Voss, R., Garven, C., & Dorr, D. A. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09457-y · Cited by 4
Pharmacological profiling of major depressive disorder-related multimorbidity clusters
Nagy, T., Gonda, X., Gézsi, A., Eszlári, N., Hullám, G., González, R., Mäkinen, H., Paajanen, T. I., Török, D., Gál, Z., et al. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.05.007 · Cited by 3
Effectiveness of Psychological Therapy for Treatment-Resistant Depression in Adults: A Systematic Review and Meta-Analysis
Giguère, S., Fortier, A., Azrak, J., Giguère, C., Potvin, S., & Dumais, A. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15080338 · Cited by 5
Is Pilates effective in improving depressive disorders? A comprehensive overview
Legnani, F., Tassi, L., Surace, T., Capuzzi, E., Caldiroli, A., Clerici, M., & Buoli, M. (2024) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000541 · Cited by 4
Shame and depressive symptoms in men: The moderating role of environmental mastery and purpose in life
Misuraca, G. O., Francis, L. M., Mansour, K. A., Greenwood, C. J., Olsson, C. A., & Macdonald, J. A. (2024) · International Journal of Social Psychiatry · doi:10.1177/00207640241263245 · Cited by 4
Peripheral CD4+ T helper lymphocytes alterations in major depressive disorder: A systematic review and meta-analysis
Fan, W., Zhu, D., Cao, L., Wang, S., Tong, Y., Xie, F., Zhang, X., Su, P., & Wang, G. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.07.027 · Cited by 5
Identifying genetic variants associated with side effects of antidepressant treatment: A systematic review
Zurchimitten, G., Camerini, L., Izídio, G. S., & Ghisleni, G. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111154 · Cited by 4
Prevalence of Antidepressant Prescription in Adolescents Newly Diagnosed with Depression in Germany
Kaur, N., Doege, C., & Kostev, K. (2024) · Children · doi:10.3390/children11101246 · Cited by 4
The Use of Melatoninergic Antidepressants for Stabilization of Remission in Depression Comorbid with Alcohol Abuse, Anxiety or Neuropsychiatric Disorders: A Systematic Review
Георгиевна, К. С., Radionov, D. S., Игоревна, Ш. Н., Kotsyubinskaya, Y. V., Yarygina, Y. V., Андреевна, Б. А., Сивакова, Н. А., Андреевна, С. Д., Yakunina, O. N., Andrianova, A. E., et al. (2024) · Consortium Psychiatricum · doi:10.17816/cp15560 · Cited by 5
Neuroprotective and Antidepressant Effects of Isorhamnetin: Mechanistic Evaluations in a Reserpine-Induced Mouse Model of Pain and Depression
Alqudah, A. M., Qnais, E. Y., Bseiso, Y., Gammoh, O., Aljabali, A. A. A., & Shilbayeh, S. A. R. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05244-2 · Cited by 4
Mediation of nutritional status between the number of teeth and depressive symptoms in multi-ethnic older adults from Western China
Tian, X., Xia, X., Li, H., Hu, Y., Xie, Y., Hu, X., Yue, J., Dong, B., Wu, B., & Wang, Y. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1506640 · Cited by 3
Differential effects of antidepressants on cognition in Alzheimer's disease with depression: A sub-group analysis of an open-label, observational study
Cumbo, E., & Migliore, D. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251340084 · Cited by 3
An Update on the Effect of Physical Exercise on Depressive Disorder: A Systematic Review with Meta-Analysis and Meta-Regression of Randomized Controlled Trials
Ramos‐Jiménez, A., Hernández‐Torres, R. P., Ramos-Hernández, J. A., Trejo-Trejo, M., & Chávez-Guevara, I. A. (2025) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk11010009 · Cited by 4
Virtual reality-based Avatar Therapy for treatment-resistant major depressive disorder: A pilot study
Giguère, S., Potvin, S., Fortier, A., Phraxayavong, K., Lespérance, F., Do, A., Bahremand, A., & Dumais, A. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117080 · Cited by 4
Economic and clinical burden of major depressive disorder with insomnia symptoms in commercially and Medicaid-insured adults in the United States: A retrospective matched cohort study
Kale, H. P., Zhdanava, M., Pilon, D., Sheehan, J. J., Drissen, T., Boonmak, P., Choudhry, Z., Shah, A., & Jha, M. K. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.12.048 · Cited by 2
Urgency to treat and early optimized treatment in major depressive disorder: consequences of delayed treatment, barriers to implementation, and practical strategies for clinicians
Oluboka, O. J., Habert, J., Khullar, A., Robinson, D. J., Katzman, M. A., Klassen, L. J., Soares, C., Chokka, P. R., Oakander, M. A., McIntyre, R. S., et al. (2025) · CNS Spectrums · doi:10.1017/s1092852925000276 · Cited by 3
GDNF attenuates a-synuclein aggregation-induced damage to VTA-NAc dopaminergic transmission and alleviates depression-like behaviors in mice
Chen, J., Ling, Z., Lv, M., Chen, S., Xu, W. G., Shao, L., Ma, Z., Wang, C., Song, Y., & Tang, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-16556-7 · Cited by 3
Depression outcomes correlated to exposure to per- and poly-fluoroalkyl substances (PFAS)
Rahman, H. H., Stokey, W. R., & Munson‐McGee, S. H. (2025) · Environmental Science and Pollution Research · doi:10.1007/s11356-025-36917-z · Cited by 4
Shenling Kaixin granules attenuate depression via multi-target mechanisms: evidence from CSDS model and cellular studies
Ji, W., Zhao, W., Xu, Y., Wang, Y., Meng, X., Xiao, H., Zhuang, X., Pan, C., Mo, T., Wang, B., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157547 · Cited by 3
Mise au point sur les liens entre diabète et dépression
Endomba, F. T., Guillaume, M., Lemogne, C., & Chauvet‐Gélinier, J. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.03.007 · Cited by 4
Characterizing the treatment patterns, medication burden, and patient demographics of older adults with major depressive disorder treated with antidepressants with or without selected comorbidities
Gannu, L., Devine, F., Popadic, L., Lal, S., Witte, M. M., Potter, M., & Hass, S. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2348603 · Cited by 3
Healthcare resource utilization with adjunctive cariprazine and other atypical antipsychotics in patients with major depressive disorder
Clayton, A. H., Parikh, M., Yee, T., Mercer, D., Haiyan, S., Cummings, N., Rava, A., Hayes, O., & Nabulsi, N. A. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2025.2465617 · Cited by 3
Patient and provider factors associated with follow-up for positive depression screens in adults: a retrospective review of University of Utah primary and specialty care clinics
Battiola, T., Ellison, T., Dummer, D., Weir, R., Kaput, K. L., & Reddy, D. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-088973 · Cited by 2
Identification of Ferroptosis‐Related Hub Genes as Diagnosis Biomarkers and Therapeutic Monitoring for Major Depressive Disorder Diagnosis
Huang, S., Xie, S., Feng, F., Wan, Y., Ma, Y., Wang, Y., Zhang, F., Chen, X., Tang, P., & Liu, X. (2025) · IET Systems Biology · doi:10.1049/syb2.70045 · Cited by 2
Integrated care for older people screening tool for measuring intrinsic capacity: Findings from national ICOPE implementation in Taiwan
Hsu, I.-L., Jia-ni, X., Hu, Y.-C., Hou, W., Wu, C.-Y., Chang, Y.-H., Jou, Y., Lo, Y., Lee, C.-Y., Wu, F. C., et al. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113187 · Cited by 2
Newly Diagnosed Mental Health Disorders in Patients With Breast Cancer Receiving Radiation Therapy
Loving, B. A., Almahariq, M. F., Sivapalan, S., Levitin, R. B., Qu, L., Ramanathan, S., Ijaz, Z., & Dilworth, J. T. (2024) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2024.03.028 · Cited by 2
The relationship between chronotype and treatment time of day on post-treatment depression symptom severity for depressed patients receiving cognitive behavioural therapy
Lau, P. H., Levitan, R. D., Quilty, L. C., Kloiber, S. M., Zai, G. C., & Laposa, J. M. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.09.121 · Cited by 3
Prevalence of Depression in Patients with Rheumatoid Arthritis attending Rheumatology clinic of Benghazi Medical Center
Boshalla, N., Aljafi, N., Albraky, F., & Roaeid, R. B. M. (2024) · Benghazi University Medical Journal · doi:10.37376/benunivmedj.v1i1.7141 · Cited by 2
Effects of Educational Program Based on Self-Esteem Enhancement on Weight Status in Obese Women
Rabiei, M. A. S., Ahmadpanah, M., Kazemzadeh, M., & Ebrahimi, S. (2024) · Iranian Journal of Nursing and Midwifery Research · doi:10.4103/ijnmr.ijnmr_160_23 · Cited by 2
Application of Anesthetic Agents in Depression
Vutskits, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93273-8.00026-2 · Cited by 1
Correlates of disability among primary care patients with common mental disorders and chronic medical conditions- a cross-sectional study from rural South India
Salazar, L. J., Hegde, D., Srinivasan, K., Heylen, E., & Ekstrand, M. L. (2024) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-024-02727-w · Cited by 1
Understanding Major Depressive Disorder in Singapore: Insights from the second Singapore Mental Health Study (SMHS 2016)
Roystonn, K., Koh, Y. S., Shafie, S., Sambasivam, R., Vaingankar, J. A., Chong, S. A., & Subramaniam, M. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.046 · Cited by 2
An In Vitro Assay to Measure Astrocyte-Dependent Synaptic Phagocytosis in Health and Major Depressive Disorder
Vesga-Jiménez, D. J., Vivi, E., & Benedetto, B. D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4366-2_14 · Cited by 1
Cancer in Severe Mental Illness Patients: A Retrospective Study
Vinais, T., Gellé, T., Preux, P., Nubukpo, P., & Lacroix, A. (2025) · Psycho-Oncology · doi:10.1002/pon.70183 · Cited by 1
3D Convolutional Neural Network Model for Detection of Major Depressive Disorder from Grey Matter Images
Bindiya, A. R., Adiga, A., & Mahanand, B. S. (2025) · Applied Sciences · doi:10.3390/app151910312 · Cited by 1
A tripartite biopsychosocial intervention program enhances mental health and quality of life in elderly patients with depression secondary to geriatric diseases
Chen, Y., Lin, X. J., & Ye, X. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1696674 · Cited by 1
Dissecting pleiotropy between major depressive disorder and physical disease comorbidities
Woodward, D. J., Reay, W. R., Wormington, B., Díaz‐Torres, S., Ong, J., Gerring, Z. F., Thorp, J. G., & Derks, E. M. (2026) · Nature Genetics · doi:10.1038/s41588-026-02735-3 · Cited by 1
Screening for Depression, Anxiety, and Suicidality: Insights From Electronic Health Record Data in an Academic Medical Center
Fatt, C. C., Jha, M. K., Vasu, S., Deane, A. E., Foster, J. A., & Trivedi, M. H. (2025) · Journal of Primary Care & Community Health · doi:10.1177/21501319251394192 · Cited by 2
The Relationship Between Economic Pressure, Emotional Neglect and Anxiety Among Chinese Left-Behind Children: Based on Response Surface Analysis
Liao, S., Wang, D., Zhang, K., & Wang, J. (2025) · Behavioral Sciences · doi:10.3390/bs15121679 · Cited by 1
Acceptance and commitment therapy for psychiatric inpatients diagnosed with depression and insomnia: a multiple-baseline single-case study
Sosic-Vasic, Z., Bergmann, M., & Kroener, J. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1673223 · Cited by 1
Error processing in major depressive disorder: a systematic review and meta-analysis of event-related potential studies
Liang, K., Hung, C.-C., Ko, C.-W., Lin, P.-C., Chan, P.-Y. S., & Cheng, C. (2026) · Clinical Neurophysiology · doi:10.1016/j.clinph.2026.2111503 · Cited by 1
Association Between Pet Attachment and Depressive Symptoms from Perspective of Regulating Effects of Alienation Sense and Oxytocin
Zhu, Y., & Qiang, L. (2026) · Issues in Mental Health Nursing · doi:10.1080/01612840.2025.2585048 · Cited by 1
Impact of Comorbid Generalized Anxiety Disorder on rTMS/iTBS Clinical Outcomes in Major Depression: A Multicenter Registry-Based Observational Study
Noda, Y., Osawa, R., Takeda, Y., Fujita, K., Tsuji, T., & Kitahata, R. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16020068 · Cited by 1
Long-term adjunctive lumateperone 42 mg treatment in major depressive disorder: Results from a 6-month open-label extension study
Durgam, S., Earley, W. R., Kozauer, S. G., Chen, C., Lakkis, H. D., & Cutler, A. J. (2026) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2026.112786 · Cited by 1
Gender Differences and Comorbidities in Major Depression
Jaber, M. H., Kahwaji, H., Eid, D., Atat, M. E., & Fakhoury, M. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-981-95-6872-7_13 · Cited by 1
DNA methylation-derived age acceleration reveals neurodevelopmental and stress-linked pathways in depression and suicide
Francis, A., & Dwivedi, Y. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121881 · Cited by 1
Current concepts of autoantibodies in mood disorders
Hansen, N., & Malchow, B. (2025) · Research Directions Depression · doi:10.1017/dep.2025.3 · Cited by 1
Evaluation of an online training course for educational professionals on depression and mental health in childhood and adolescence
Saffenreuther, A.-K., Greimel, E., Primbs, R., Iglhaut, L., Kaubisch, S., Schulte‐Körne, G., & Feldmann, L. (2025) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-025-01007-y · Cited by 1
Mecanismos fisiopatológicos da depressão relacionados à perda de memória
Mateus, A. O., Marques, M. H. N., de Freitas, C. T. A., Costa, R., Maciel, G. C., & Santos, M. S. (2024) · Revista Neurociências · doi:10.34024/rnc.2024.v32.15684
DEPRESSÃO E COMORBIDADES PSIQUIÁTRICAS: UMA REVISÃO BIBLIOGRÁFICA
Cardoso, A. M. S., Yamashita, F. A., Mezzomo, L. E., Savelli, E. V. M., Rocha, M. M., de Medeiros, S. G. L., Mesquita, F. D. S., Moreira, E. D. M., & Yamashita, I. A. (2024) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v5i2.4868
Effects of transcranial photobiomodulation on peripheral biomarkers associated with oxidative stress and complex IV activity in the prefrontal cortex in rats subjected to chronic mild stressPreprint
Bortoluzzi, L., Colombo, R., Pinto, K. B. D. M., Viscardi, L. H., Missiaggia, R., Turella, D. J. P., Schwantess, L., Salvador, M. M., Branco, C. S., Rigotti, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.27.597940
Outcomes of a Depression Screening and Postscreen Intervention Pilot Program in Specialty Clinics
Asuquo, S. E., Girardi, P., Dummer, D., Bakian, A. V., & Weir, R. A. (2024) · Psychiatric Services · doi:10.1176/appi.ps.20240049
Non-steroidal Anti-inflammatory Drugs (NSAIDs) in Major Depressive Disorder (MDD) Treatment
He, Q., Bennett, A. N., & Chan, K. H. K. (2025) · Springer eBooks · doi:10.1007/978-3-031-32035-4_28-1
Suicidal Ideation, Behaviors, and Deaths in People With Ménière's Disease: A Systematic Review
McCray, L. R., Farmer, H. G., Nguyen, S. A., Staab, J. P., Nguyen, J. P., Kil, J., & Rizk, H. G. (2025) · Otolaryngology · doi:10.1002/ohn.1216

Authors: Arnaud, A. M., Brister, T. S., Duckworth, K., Foxworth, P., Fulwider, T., Suthoff, E. D., Werneburg, B., Aleksanderek, I., & Reinhart, M. L.
Affiliations: Sage Therapeutics (United States) (US)
National Alliance on Mental Illness (US)
Corresponding author: Suthoff, Ellison D.
ORCID: Arnaud, Alix M.
Brister, Teri S.
Duckworth, Ken
Suthoff, Ellison D.
Venue: The Journal of Clinical Psychiatry
Publisher: Physicians Postgraduate Press, Inc
Published: 2022-10-19
Volume: 83
Issue: 6
ISSN: 0160-6689 (ISSN-L)
1555-2101
DOI: 10.4088/jcp.21r14328
OpenAlex: W4306753808
Cited by: 149
References: 1
Citations by year: 2026: 42 · 2025: 54 · 2024: 39 · 2023: 13 · 2022: 1
FWCI: 25.28
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The Journal of Clinical Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: Biogen
Sage Therapeutics
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords: major depressive disorder, comorbidities, dementia, Alzheimer's disease, cognitive decline, cardiovascular disease, stroke, metabolic syndrome, diabetes mellitus, obesity, autoimmune disease, HIV/AIDS, substance abuse, alcohol abuse, drug abuse, comorbidity risk factors
MeSH terms: Alzheimer Disease, Major Depressive Disorder, Female, Humans, Male, Comorbidity, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Impact of Major Depressive Disorder on Comorbidities: A Systematic Literature Review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks